Clinical Trial Update: B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B [Phase 3]

View source ↗

Summary

A Phase 3 trial (BEe-HIVe) evaluated HEPLISAV-B for hepatitis B vaccination in persons living with HIV. The study has completed and results were posted on 2025-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• HEPLISAV-B (hepatitis B vaccine, adjuvanted)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection, Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2025-07-20